Iterum Therap
ITRM----
Iterum Therap (ITRM)
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the U...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Iterum Therap Analyst Rating
View MoreForecast & Rating
Mar 4, 2026Price forecast
$9.0029900.00%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · May 11 at 09:30 PM
Keenova Reports First Quarter 2026 Financial Results | MNK Stock News
- prnewswire · May 4 at 07:09 AM
08:09 ETIterion Therapeutics Announces Oral Presentation of Phase 1/2 Tegavivint Data in Advanced Hepatocellular Carcinoma at the 2026 ASCO Annual Meeting
- StockTitan · May 3 at 10:30 PM
Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock News
- StockTitan · Apr 30 at 10:30 PM
Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock News
- Thehill · Apr 29 at 11:12 AM
Antibiotic resistance is growing — don't delay new antibiotics
- MorningStar · Apr 13 at 07:20 AM
Iterion Presents New Data on First-in-Class TBL1 Inhibitor Tegavivint, Targeting Wnt-Driven Cancers at AACR Annual Meeting
